I
IMVT
Immunovant Inc
28.41
-0.69-2.37%After Hours: 28.03 -0.38 -1.34%19:30 10/23 EDT
OPEN/PREV CLOSE28.25/28.17
TODAY RANGE28.01-28.96
VOL1.06M
MARKET CAP5.97B
52 WEEK RANGE19.21-45.42
AVG VOL (3M)1.34M
% TURNOVER0.43%
TURNOVER--
P/E (TTM)-10.2765
% RANGE3.39%
EPS(TTM)-2.8103
P/E(FORWARD)-9.7824
P/B8.10
BVPS3.565
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.58B
SHARES OUTSTANDING206.55M
NEXT EARNINGS11/09-11/13
FREE FLOAT89.50M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·10/20 07:48
Immunovant: Batoclimab 2.0 Bull Case Flawed By Mixed Data, Competitive Threats
Benzinga·10/14 08:59
Immunovant Q1 2027 Earnings Call: Complete Transcript
TipRanks·10/12 12:28
Immunovant (IMVT) Gets a Buy from Bank of America Securities
Simply Wall St·10/10 15:36
How Investors May Respond To Immunovant (IMVT) After Sjögren’s Trial Failure
TipRanks·10/08 15:00
Immunovant down after Argenx study fails in Sjogren’s disease
TipRanks·10/08 15:00
Argenx has ‘good news and bad news’ day, says H.C. Wainwright
Benzinga·10/08 12:07
Argenx, Caribou Biosciences And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
Benzinga·10/08 08:32
Why Applied Digital Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Simply Wall St·10/04 20:16
Is Immunovant (IMVT) Undervalued On Its CLE Trial Setback?
Simply Wall St·10/02 06:25
Is Trial Failure Altering The Investment Case For Immunovant Stock (IMVT)?
Simply Wall St·09/26 16:27
Is Immunovant (IMVT) Undervalued As CLE Trial Results Raise Fresh Questions?
TipRanks·09/26 14:35
Immunovant (IMVT) Receives a Rating Update from a Top Analyst
Simply Wall St·09/24 19:32
How Investors May Respond To Immunovant (IMVT) Skin Lupus Drug Halt
Same Industry
Name/Symbol
Change%
Price